Thalidomide Maintenance Following High-Dose Melphalan with Autologous Stem Cell Support in Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thalidomide Maintenance Following High-Dose Melphalan with Autologous Stem Cell Support in Myeloma

Published:2008-06 Issue:3 Volume:8 Page:153-158
ISSN:1557-9190
Container-title:Clinical Lymphoma and Myeloma
language:en
Short-container-title:Clinical Lymphoma and Myeloma

Author:

Chang Julie E.,Juckett Mark B.,Callander Natalie S.,Kahl Brad S.,Gangnon Ronald E.,Mitchell Teri L.,Longo Walter L.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference19 articles.

1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma;Attal;N Engl J Med,1996

2. Standard therapy versus autologous transplantation in multiple myeloma;Attal;Hematol Oncol Clin North Am,1997

3. Clinical experience with thalidomide in multiple myeloma: phase II trial results in refractory disease and ongoing studies;Munshi;Semin Hematol,2000

4. Thalidomide for resistant and relapsing myeloma;Alexanian;Semin Hematol,2000

5. Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent;Zomas;Bone Marrow Transplant,2000

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of secondary primary malignancies in maintenance therapy for multiple myeloma;International Journal of Hematologic Oncology;2013-08

2. Long-term results of thalidomide and dexamethasone (thal–dex) as therapy of first relapse in multiple myeloma;Annals of Hematology;2011-09-08

3. Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma;Haematologica;2011-05-23

4. Combination of IFN-α/Gm-CSF as a Maintenance Therapy for Multiple Myeloma Patients after Autologous Stem Cell Transplantation (ASCT): A Prospective Phase II Study;Clinical Medicine Insights: Oncology;2010-01

5. Current Awareness in Hematological Oncology;Hematological Oncology;2008-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3